<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is involved in numerous <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to classical lesions such as endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, there are other disorders of the lymphoid system that are discussed in relation to EBV: B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in immunosuppressed individuals </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and, to some extent, primary extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Studies of the EBV expression in classical and nonclassical lesions could lead to the better understanding of different EBV mechanisms in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
</text></document>